What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Radiation therapy
Lena Specht mostly deals with Radiation therapy, Nuclear medicine, Internal medicine, Oncology and Surgery.
Lena Specht combines subjects such as Stage, Breast cancer and Lymphoma, Hodgkin's lymphoma with her study of Radiation therapy.
Her Stage research is multidisciplinary, incorporating elements of BEACOPP and Chemotherapy.
Her Nuclear medicine research incorporates elements of ABVD, Lung, Breathing and Dacarbazine.
Her Oncology research incorporates themes from Odds ratio, Randomized controlled trial, Risk factor and Hazard ratio.
Her Surgery study combines topics from a wide range of disciplines, such as Univariate analysis and Standard treatment.
Her most cited work include:
- Revised response criteria for malignant lymphoma (3306 citations)
- Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study (648 citations)
- FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma (581 citations)
What are the main themes of her work throughout her whole career to date?
Lena Specht mainly focuses on Radiation therapy, Internal medicine, Oncology, Radiology and Nuclear medicine.
Her Radiation therapy research includes themes of Stage, Disease, Chemotherapy and Lymphoma.
Internal medicine is closely attributed to Gastroenterology in her study.
In general Oncology study, her work on Chemotherapy regimen often relates to the realm of In patient, thereby connecting several areas of interest.
While the research belongs to areas of Radiology, Lena Specht spends her time largely on the problem of Lung cancer, intersecting her research to questions surrounding Locally advanced.
Her study in Nuclear medicine is interdisciplinary in nature, drawing from both Breast cancer, Planning target volume, Lung and Computed tomography.
She most often published in these fields:
- Radiation therapy (49.39%)
- Internal medicine (40.88%)
- Oncology (28.71%)
What were the highlights of her more recent work (between 2015-2021)?
- Internal medicine (40.88%)
- Radiation therapy (49.39%)
- Oncology (28.71%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Radiation therapy, Oncology, Lymphoma and Radiology.
Her biological study spans a wide range of topics, including Deep inspiration breath-hold, Lung cancer, Nuclear medicine and Stage.
Her work in the fields of Positron emission tomography overlaps with other areas such as Image quality.
Her work in the fields of Oncology, such as Progression-free survival, intersects with other areas such as In patient.
Her studies deal with areas such as Survival analysis and Population based study as well as Progression-free survival.
Her Lymphoma research focuses on Leukemia and how it connects with Bone marrow.
Between 2015 and 2021, her most popular works were:
- Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma : Final Results of the Randomized EORTC/LYSA/FIL H10 Trial (183 citations)
- Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014. (76 citations)
- Novel nomograms for survival and progression in HPV+ and HPV- oropharyngeal cancer: a population-based study of 1,542 consecutive patients (47 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Radiation therapy
Her scientific interests lie mostly in Internal medicine, Radiation therapy, Oncology, Nuclear medicine and Lymphoma.
Her Radiation therapy research is under the purview of Radiology.
The study incorporates disciplines such as Hematopoietic stem cell transplantation, Refractory, Salvage therapy, Chemotherapy and Hazard ratio in addition to Oncology.
Lena Specht interconnects Vinblastine, Effective diffusion coefficient, Dacarbazine and Hounsfield scale in the investigation of issues within Nuclear medicine.
Her Lymphoma study incorporates themes from Chemotherapy regimen, Proton therapy, Radiation oncology, Disease and Leukemia.
Her biological study deals with issues like Hodgkin lymphoma, which deal with fields such as Stage.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
